Decoding hepatocarcinogenesis from a noncoding RNAs perspective

• Published in: Journal of cellular physiology Vol. 238; no. 9; pp. 1982 - 2009
• Main Authors: El-Aziz, Mostafa K Abd, Dawoud, Alyaa, Kiriacos, Caroline J, Fahmy, Sherif Ashraf, Hamdy, Nadia M, Youness, Rana A
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01-09-2023
• Subjects: Biomarkers; Circular RNA; Decoding; Drug development; Hepatocellular carcinoma; Liver cancer; Malignancy; miRNA; Non-coding RNA; Pathophysiology; Proteins; Tumorigenesis; lncRNAs; circRNAs; hepatocellular carcinoma (HCC); LincRNAs; microRNAs (miRNAs)
• ISSN: 0021-9541; 1097-4652
• DOI: 10.1002/jcp.31076

Being a leading lethal malignancy worldwide, the pathophysiology of hepatocellular carcinoma (HCC) has gained a lot of interest. Yet, underlying mechanistic basis of the liver tumorigenesis is poorly understood. The role of some coding genes and their respective translated proteins, then later on, some noncoding RNAs (ncRNAs) such as microRNAs have been extensively studied in context of HCC pathophysiology; however, the implication of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in HCC is indeed less investigated. As a subclass of the ncRNAs which has been elusive for long time ago, lncRNAs was found to be involved in plentiful cellular functions such as DNA, RNA, and proteins regulation. Hence, it is undisputed that lncRNAs dysregulation profoundly contributes to HCC via diverse etiologies. Accordingly, lncRNAs represent a hot research topic that requires prime focus in HCC. In this review, the authors discuss breakthrough discoveries involving lncRNAs and circRNAs dysregulation that have contributed to the contemporary concepts of HCC pathophysiology and how these concepts could be leveraged as potential novel diagnostic and prognostic HCC biomarkers. Further, this review article sheds light on future trends, thereby discussing the pathological roles of lncRNAs and circRNAs in HCC proliferation, migration, and epithelial-to-mesenchymal transition. Along this line of reasoning, future recommendations of how these targets could be exploited to achieve effective HCC-related drug development is highlighted.